UPDATE : Friday, May 24, 2019
상단여백
GC starts P1 trials of hemophilia treatment
GC said Thursday that it has administered the first dose of MG1113, a hemop...
by Lee Han-soo  |  2019-02-28 16:45
라인
Bukwang to sell Novartis’ chronic hepatitis B treatment
Bukwang Pharmaceutical said Thursday that it has just begun domestic market...
by Lee Han-soo  |  2019-02-28 14:59
라인
Chong Kun Dang topped clinical trials in 2018
Local drugmaker Chong Kun Dang won approval for clinical trials the most am...
by Lee Hye-seon  |  2019-02-28 10:50
라인
Korea’s 30th novel drug K-Cab to get insurance benefit from March
Korea’s 30th novel medicine K-Cab Tab. (ingredient: tegoprazan) will receiv...
by Lee Hye-seon  |  2019-02-27 16:47
라인
Korea’s drug exports hit record high in 2018, industry group says
Won Hee-mok, president of the Korea Pharmaceutical and Bio-Pharma Manufactu...
by Kim Yun-mi  |  2019-02-27 13:08
라인
GC unveils P1 results for hepatitis B treatment
GC said Monday that it has presented the phase 1 clinical trial results for...
by Lee Han-soo  |  2019-02-26 16:07
라인
‘Heat-not-burn cigarettes as risky as traditional ones’
An expert pointed out how harmful so-called “heat-not-burn” cigarettes coul...
by Kim Yun-mi  |  2019-02-26 15:45
라인
Yuclid’s antiplatelet effect confirmed in patients undergoing carotid artery stenting
Local researchers said they confirmed the antiplatelet efficacy of Yuyu Pha...
by Lee Hye-seon  |  2019-02-26 14:36
라인
‘Hardy kiwi extract can treat psoriasis’
Viromed said Monday that it has scientifically identified ow PG102, a singl...
by Lee Han-soo  |  2019-02-26 14:34
라인
Daewon licenses in Tium Bio’s endometriosis drug candidate
Daewon Pharmaceutical said Tuesday that it has signed a licensing agreement...
by Lee Han-soo  |  2019-02-26 13:58
라인
CrystalGenomics’ US partner applies for P1 trial for leukemia treatment
CrystalGenomics said Tuesday that Aptose Bioscience, its U.S. partner, has ...
by Lee Han-soo  |  2019-02-26 11:29
라인
Regulator OKs GC’s P3 trial of BCG vaccine
GC said Monday that the Ministry of Food and Drug Safety has approved its p...
by Lee Han-soo  |  2019-02-25 14:07
라인
Lung cancer 2nd treatment Alunbrig likely to get insurance coverage
The National Health Insurance Service’s drug price assessment committee rec...
by Kim Yun-mi  |  2019-02-25 14:06
라인
Regulator OKs Bukwang’s anticancer treatment
Bukwang Pharmaceutical said Thursday that the Ministry of Food and Drug Saf...
by Lee Han-soo  |  2019-02-22 15:29
라인
Will first-ever treatment for nonalcoholic fatty liver arrive?
Pharmaceutical firms around the world are striving to become the world’s fi...
by Kim Yun-mi  |  2019-02-22 15:29
라인
Hugel hits record-high quarterly sales
Hugel said Friday it registered highest quarterly turnover in the final thr...
by Lee Han-soo  |  2019-02-22 13:30
라인
Huons posts record-high sales in 2018
Huons said Wednesday that it registered 328.6 billion won ($291.9 million) ...
by Lee Han-soo  |  2019-02-21 17:17
라인
Mediforum verifies safety, efficacy of dementia treatment candidate
Mediforum said Thursday it has verified the safety and efficacy of PM012, a...
by Lee Han-soo  |  2019-02-21 15:13
라인
DPP-4 inhibitors raise bullous pemphigoid risk in diabetic patients: study
Inhibitors of dipeptidyl peptidase 4 (DPP-4), used to treat diabetes, can i...
by Kim Yun-mi  |  2019-02-21 15:13
라인
Xtandi adds indication for non-metastatic castration-resistant prostate cancer
Astellas Pharma Korea said it obtained regulatory approval for Xtandi (ingr...
by Kim Yun-mi  |  2019-02-21 15:10
여백
여백
여백
Back to Top